User profiles for Lloyd B. Mulenga

lloyd mulenga

Ministry of Health, University Teaching Hospital, University of Zambia, Vanderbilt University
Verified email at moh.gov.zm
Cited by 2919

[HTML][HTML] Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey

LB Mulenga, JZ Hines, S Fwoloshi, L Chirwa… - The Lancet Global …, 2021 - thelancet.com
Background Between March and December, 2020, more than 20 000 laboratory-confirmed
cases of SARS-CoV-2 infection were reported in Zambia. However, the number of SARS-CoV…

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia

LB Mulenga, G Kruse, S Lakhi, RA Cantrell, SE Reid… - Aids, 2008 - journals.lww.com
Objective: To examine the association between baseline renal insufficiency and mortality
among adults initiating antiretroviral therapy (ART) in an urban African setting. Design: Open …

[HTML][HTML] Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: prevalence and associated factors

BM Hamooya, LB Mulenga, SK Masenga, I Fwemba… - Medicine, 2021 - journals.lww.com
Metabolic syndrome (MetS) is a constellation of factors including hypertension, abdominal
obesity, dyslipidemia, and insulin resistance that separately and together significantly …

Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia

BH Chi, RA Cantrell, I Zulu, LB Mulenga… - International journal …, 2009 - academic.oup.com
Background High-level adherence to antiretroviral therapy (ART) is associated with favourable
patient outcomes. In resource-constrained settings, however, there are few validated …

Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy

JD Goldman, RA Cantrell, LB Mulenga… - AIDS research and …, 2008 - liebertpub.com
We evaluated the association between two antiretroviral therapy (ART) adherence
measurements—the medication possession ratio (MPR) and patient self-report—and detectable HIV …

[HTML][HTML] Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage …

…, DV Glidden, E Chizema, LB Mulenga… - PLoS …, 2019 - journals.plos.org
Background Although the success of HIV treatment programs depends on retention and viral
suppression, routine program monitoring of these outcomes may be incomplete. We used …

Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID‐19

…, C Katureebe, S Agolory, LB Mulenga… - Journal of the …, 2022 - Wiley Online Library
Introduction The potential disruption in antiretroviral therapy (ART) services in Africa at the
start of the COVID‐19 pandemic raised concern for increased morbidity and mortality among …

Impact of antiretroviral therapy on liver fibrosis among human immunodeficiency virus-infected adults with and without HBV coinfection in Zambia

…, E Sinkala, R Chilengi, LB Mulenga… - Clinical infectious …, 2017 - academic.oup.com
Background. We investigated changes in hepatic fibrosis, based on transient elastography (TE),
among human immunodeficiency virus (HIV)–infected patients with and without hepatitis …

Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia

…, LB Mulenga, B Tambatamba-Chapula… - JAIDS Journal of …, 2010 - journals.lww.com
Background: In July 2007, amid some controversy over cost, Zambia was the first African
country to introduce tenofovir (TDF) as a component of first-line antiretroviral therapy (ART) on a …

An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs

…, W Mutale, M Limbada, LB Mulenga… - American journal of …, 2010 - academic.oup.com
In many programs providing antiretroviral therapy (ART), clinicians report substantial patient
attrition; however, there are no consensus criteria for defining patient loss to follow-up (LTFU…